Harnessing Tumor-Infiltrating Lymphocytes in Triple-Negative Breast Cancer: Opportunities and Barriers to Clinical Integration.

Int J Mol Sci · 2025 · PMC12072607 · PMID 40362529

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

Their analysis also included iTILs and observed similar improved outcomes with higher iTILs, but since only 15% of the tumors had >10% iTILs, the results did not reach statistical significance [ 46 ].

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.